![]()
![]()
| CHO cell |
Chinese hamster ovary cell |
| Complex Carbohydrate |
Polysaccharide polymer |
| Cytotoxin |
Any substance that poisons living cells |
| Endoplasmic reticulum |
A system of double-membraned, tubular organelles that aid in protein synthesis in eukaryotic cells |
| Enzymatic synthesis |
Any chemical reaction or series of reactions catalysed by an enzyme |
| Enzyme |
Proteins that act as catalysts, speeding the rate at which biochemical reactions proceed but not altering the direction or nature of the reactions |
| Expression system |
An expression vector, its cloned DNA, and the host for the vector |
| Fermenters |
A device used to grow large amounts of bacteria in liquid culture. The device generally can hold more than 10 liters of liquid growth medium, has a heater to provide constant temperature, and has an agitator for aeration |
| Glycan |
A generic term for any sugar or assembly of sugars, in free form or attached to another molecule, used interchangeably with the term saccharide or carbohydrate |
| GlycoAdvance™ |
A protein glycosylation technology solution, utilizing a proprietary library of recombinant glycosyltransferase enzymes, sugar nucleotides and sugars to re-build the incomplete or incorrect glycosylated structure of protein drugs |
| GlycoConjugation™ |
A strategy of conjugating bioactive or functional moieties with either antibodies or glycoproteins through a sugar residue linkage |
| Glycoforms |
Different molecular forms of a glycoprotein, resulting from variable glycan structure and/or glycan attachment site occupancy |
| GlycoPEGylation™ |
Selective addition of the hydrophilic polymer, polyethylene glycol to therapeutic based proteins via the glycans |
| Glycoprotein |
A protein with one or more covalently bound glycans |
| Glycosylation |
The enzyme-catalyzed covalent attachment of a carbohydrate to a polypeptide, lipid, polynucleotide, carbohydrate, or other organic compound, generally catalyzed by glycosyltransferases, utilizing specific sugar nucleotide donor substrates |
| Glycosyltransferase |
Enzyme that catalyzes transfer of a sugar from a sugar nucleotide donor to a substrate |
| Golgi apparatus |
A cellular organelle of the cytoplasmic membrane. It is covered with cisternae, a closed, fluid-filled sac or vesicle, and is involved in secretory processes |
| Half-life |
The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent |
| Immunogenicity |
Describes the quality of a substance which is able to provoke an immune response against the substance |
| IND |
FDA Investigational New Drug (IND) Application Process |
| Monosaccharides |
Carbohydrate that can not be hydrolyzed into a simpler carbohydrate The building block of oligosaccharides and polysaccharides. |
| N-glycans |
An N-linked oligosaccharide |
| Organic synthesis |
Experimental methods for the synthesis of organic compounds |
| PEG |
Polyethylene glycol |
| Pharmacodynamic (PD) |
This is the science concerned with the study of the way in which drugs and other chemicals exert their effects on living organisms |
| Pharmacokinetic (PK) |
This is the science which describes quantitatively the uptake of drugs by the body, their biotransformation, their distribution, metabolism, and elimination from the body |
| Post Translational Modification |
Alterations made to a protein after translation in the golgi by ribosomes such as proteolytic cleavage, carbohydrate/sugar attachment, methylation, or phosphylation |
| Proteolytic degredation |
Complete breakdown of polypeptides to their amino acids |
| Recombinant |
A fragment of DNA incorporated artificially into the DNA molecule of a suitable vector so that it can express itself many times. This way a large quantity of the DNA in question can be obtained. The DNA is usually one that contains genes of interest |
| Reticuloendothelial system (RES) |
A system of phagocytes (cells which engulf and devour other cells) which can be found all over the body but are mostly concentrated in the liver, spleen, lymph nodes, and bone marrow, and are a part of the body's immune system |
| Sialylation |
The attachment of sialic acid to the terminating positions of a glycoprotein via the enzyme sialyltransferase |
| Sugar nucleotide |
Activated forms of monosaccharides, such as UDP-Gal, GDP-Fuc, and CMP-Sia, typically used as donor substrates by glycosyltransferases |
| Sugars |
A generic term often used to refer to any carbohydrate, but most frequently to low-molecular-weight carbohydrates that are sweet in taste |
| Transferrin |
A family of metal-binding proteins with an in-vivo preference for ferric iron |
| Transgenics |
This term describes an organism that has had genes from another organism put into its genome through recombinant DNA techniques |